NRx Change In Cash from 2010 to 2025

NRXPW Stock  USD 0.18  0.03  20.00%   
NRx Pharmaceuticals Change In Cash yearly trend continues to be fairly stable with very little volatility. Change In Cash is likely to outpace its year average in 2025. During the period from 2010 to 2025, NRx Pharmaceuticals Change In Cash regression line of quarterly data had mean square error of 82 T and geometric mean of  1,096,711. View All Fundamentals
 
Change In Cash  
First Reported
2017-12-31
Previous Quarter
579 K
Current Value
-252 K
Quarterly Volatility
7.1 M
 
Covid
Check NRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 K, Interest Expense of 131.1 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRx financial statements analysis is a perfect complement when working with NRx Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRx Pharmaceuticals Correlation against competitors.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

Latest NRx Pharmaceuticals' Change In Cash Growth Pattern

Below is the plot of the Change In Cash of NRx Pharmaceuticals over the last few years. It is NRx Pharmaceuticals' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRx Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Slightly volatile
   Change In Cash   
       Timeline  

NRx Change In Cash Regression Statistics

Arithmetic Mean(1,266,683)
Geometric Mean1,096,711
Coefficient Of Variation(736.15)
Mean Deviation5,634,227
Median449,374
Standard Deviation9,324,628
Sample Variance86.9T
Range41.2M
R-Value(0.35)
Mean Square Error82T
R-Squared0.12
Significance0.19
Slope(678,293)
Total Sum of Squares1304.2T

NRx Change In Cash History

2025-13.2 M
2024-13.9 M
2023-15.5 M
2022-7.6 M
202125.7 M
2020982 K
2019-11.1 K

About NRx Pharmaceuticals Financial Statements

NRx Pharmaceuticals investors use historical fundamental indicators, such as NRx Pharmaceuticals' Change In Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NRx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash-13.9 M-13.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.